MDSC are cells of myeloid origin that emerge in almost all cancer types and are able to suppress T-cell functionality through several mechanisms such as the release of the arginine-degrading enzyme arginase-I (ARG1), ROS and prostaglandins. Here, ARG1 is linked to cancer.